Millennium's Vision Thing
Executive Summary
Millennium's purchase of Leukosite appears to be a significant step towards its oft-stated goal of building a fully integrated pharmaceutical company. But some of the company's investors reacted less enthusiastically as stock prices tumbled immediately after the deal. Since then, the company's share price has almost returned to pre-deal levels. And Millennium's management says that it will reap tremendous benefits as the result of acquiring Leukosite's pipeline and late-stage clinical development capabilities,